Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(21/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(21/week)
News
United States
(589/week)
Manufacturing
(402/week)
Energy
(331/week)
Technology
(413/week)
Utilities
(228/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Cancer immunotherapy
Mar 23, 2020
First-of-its-kind Engineered Macrophage Cell Therapy Platform Shows Ability to Reduce Tumor Burden and Activate Anti-Tumor Immunity, Improving Overall Survival in Pre-Clinical Cancer Models
Mar 17, 2020
4D Pharma Presents Additional Interim Clinical Data From Combination Study for Lead Oncology Candidate
Mar 16, 2020
Blueprint Medicines Announces Part 1 Results from PIONEER Trial Showing Broad Activity of Avapritinib Across Measures of Mast Cell Burden, Clinical Outcomes and Quality of Life in Indolent Systemic Mastocytosis
Mar 16, 2020
Leap Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results
Mar 16, 2020
EnGeneIC Announces Publication in Cancer Cell of a Scientific Paper Highlighting the Ability of EDV(TM) Nanocells to Mount Dual Assault on Cancer Cells
Mar 13, 2020
EMD Serono and Pfizer Provide Update on Phase III JAVELIN Head and Neck 100 Study
Mar 12, 2020
Agenus Receives Fast Track Designation for Balstilimab & Zalifrelimab in Advanced Cervical Cancer
Mar 12, 2020
Marker Therapeutics Reports Full Year 2019 Operating and Financial Results
Mar 10, 2020
First QS-21 Royalty Payment Due to Agenus is Triggered
Mar 10, 2020
Phio Pharmaceuticals and Helmholtz Zentrum München Announce Collaboration and Option Agreement with Medigene
Mar 09, 2020
Compugen Announces Updated Clinical Data from Ongoing COM701 Phase 1 Study
Mar 05, 2020
Outlook on the $320M+ Bladder Cancer Drugs Market, 2020-2030
Mar 05, 2020
Oncolytics Biotech® Reports Fourth Quarter and Full Year 2019 Financial Results and Operational Highlights
Mar 04, 2020
Nexelis to Acquire Specialty Immunogenicity and Immune-Oncology Testing Laboratory ImmunXperts
Mar 03, 2020
BioInvent and Transgene to Present Data on BT-001, an Oncolytic Virus Encoding for an Anti-CTLA4 Antibody, at Upcoming Congresses
Mar 03, 2020
Avectas and CCRM Announce Collaboration to Accelerate Development of Novel Technology for Cell Therapies
Mar 02, 2020
Anixa Biosciences Announces Presentation at AI and Big Data in Cancer Conference
Mar 02, 2020
Marker Therapeutics and Aspire Capital Enter into a Common Stock Purchase Agreement for up to $30 million
Mar 02, 2020
Primmune Therapeutics Raises $7 Million Seed Financing to Develop Novel Oral TLR7 Immunotherapies for Cancer and Acute Viral Diseases
Mar 02, 2020
Primmune Therapeutics Raises $7 Million Seed Financing to Develop Novel Oral TLR7 Immunotherapies for Cancer and Acute Viral Diseases
‹‹
Page 8
››
Latest News
May 11, 2024
Sky Harbour to Report 2024 Q1 Results and Host Webcast Investor Call Tuesday, May 14, 2024
May 11, 2024
SpinLaunch Board Announces Leadership Transition
May 11, 2024
Altisource Asset Management Corporation Posts Progress Reports on Project Alpha, Phase II, Through April 2024
May 11, 2024
Albany International Declares Dividend
May 11, 2024
GE Vernova Recommends Shareholders Reject “Mini-Tender” Offer by TRC Capital Investment Corporation
May 11, 2024
Westlake Corporation Declares Quarterly Dividend
May 11, 2024
JBT Corporation Declares Quarterly Dividend
May 11, 2024
Ingersoll Rand Successfully Completes $3,300 Million Senior Unsecured Bond Offering and New $2,600 Million...
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events